Testosterone Induces Vascular Smooth Muscle Cell Migration by NADPH Oxidase and c-Src–Dependent Pathways

  • Andreia Z. Chignalia
    From the Institute of Biomedical Sciences (A.Z.C., E.Z.S., L.L.C., L.R.L., M.H.C.C., Z.B.F., R.C.T.), and Heart Institute, School of Medicine (A.Z.C., F.R.L.), University of São Paulo, São Paulo, Brazil; Kidney Research Centre (A.Z.C., E.Z.S., A.C.M., G.E.C., R.M.T.), Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada; Section of Experimental Endocrinology (M.C.W.A.), Department of Pharmacology, Federal University of São Paulo, Sao Paulo, Brazil; Department of...
  • Elke Z. Schuldt
    From the Institute of Biomedical Sciences (A.Z.C., E.Z.S., L.L.C., L.R.L., M.H.C.C., Z.B.F., R.C.T.), and Heart Institute, School of Medicine (A.Z.C., F.R.L.), University of São Paulo, São Paulo, Brazil; Kidney Research Centre (A.Z.C., E.Z.S., A.C.M., G.E.C., R.M.T.), Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada; Section of Experimental Endocrinology (M.C.W.A.), Department of Pharmacology, Federal University of São Paulo, Sao Paulo, Brazil; Department of...
  • Lívia L. Camargo
    From the Institute of Biomedical Sciences (A.Z.C., E.Z.S., L.L.C., L.R.L., M.H.C.C., Z.B.F., R.C.T.), and Heart Institute, School of Medicine (A.Z.C., F.R.L.), University of São Paulo, São Paulo, Brazil; Kidney Research Centre (A.Z.C., E.Z.S., A.C.M., G.E.C., R.M.T.), Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada; Section of Experimental Endocrinology (M.C.W.A.), Department of Pharmacology, Federal University of São Paulo, Sao Paulo, Brazil; Department of...
  • Augusto C. Montezano
    From the Institute of Biomedical Sciences (A.Z.C., E.Z.S., L.L.C., L.R.L., M.H.C.C., Z.B.F., R.C.T.), and Heart Institute, School of Medicine (A.Z.C., F.R.L.), University of São Paulo, São Paulo, Brazil; Kidney Research Centre (A.Z.C., E.Z.S., A.C.M., G.E.C., R.M.T.), Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada; Section of Experimental Endocrinology (M.C.W.A.), Department of Pharmacology, Federal University of São Paulo, Sao Paulo, Brazil; Department of...
  • Gláucia E. Callera
    From the Institute of Biomedical Sciences (A.Z.C., E.Z.S., L.L.C., L.R.L., M.H.C.C., Z.B.F., R.C.T.), and Heart Institute, School of Medicine (A.Z.C., F.R.L.), University of São Paulo, São Paulo, Brazil; Kidney Research Centre (A.Z.C., E.Z.S., A.C.M., G.E.C., R.M.T.), Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada; Section of Experimental Endocrinology (M.C.W.A.), Department of Pharmacology, Federal University of São Paulo, Sao Paulo, Brazil; Department of...
  • Francisco R. Laurindo
    From the Institute of Biomedical Sciences (A.Z.C., E.Z.S., L.L.C., L.R.L., M.H.C.C., Z.B.F., R.C.T.), and Heart Institute, School of Medicine (A.Z.C., F.R.L.), University of São Paulo, São Paulo, Brazil; Kidney Research Centre (A.Z.C., E.Z.S., A.C.M., G.E.C., R.M.T.), Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada; Section of Experimental Endocrinology (M.C.W.A.), Department of Pharmacology, Federal University of São Paulo, Sao Paulo, Brazil; Department of...
  • Lucia R. Lopes
    From the Institute of Biomedical Sciences (A.Z.C., E.Z.S., L.L.C., L.R.L., M.H.C.C., Z.B.F., R.C.T.), and Heart Institute, School of Medicine (A.Z.C., F.R.L.), University of São Paulo, São Paulo, Brazil; Kidney Research Centre (A.Z.C., E.Z.S., A.C.M., G.E.C., R.M.T.), Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada; Section of Experimental Endocrinology (M.C.W.A.), Department of Pharmacology, Federal University of São Paulo, Sao Paulo, Brazil; Department of...
  • Maria Christina W. Avellar
    From the Institute of Biomedical Sciences (A.Z.C., E.Z.S., L.L.C., L.R.L., M.H.C.C., Z.B.F., R.C.T.), and Heart Institute, School of Medicine (A.Z.C., F.R.L.), University of São Paulo, São Paulo, Brazil; Kidney Research Centre (A.Z.C., E.Z.S., A.C.M., G.E.C., R.M.T.), Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada; Section of Experimental Endocrinology (M.C.W.A.), Department of Pharmacology, Federal University of São Paulo, Sao Paulo, Brazil; Department of...
  • Maria Helena C. Carvalho
    From the Institute of Biomedical Sciences (A.Z.C., E.Z.S., L.L.C., L.R.L., M.H.C.C., Z.B.F., R.C.T.), and Heart Institute, School of Medicine (A.Z.C., F.R.L.), University of São Paulo, São Paulo, Brazil; Kidney Research Centre (A.Z.C., E.Z.S., A.C.M., G.E.C., R.M.T.), Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada; Section of Experimental Endocrinology (M.C.W.A.), Department of Pharmacology, Federal University of São Paulo, Sao Paulo, Brazil; Department of...
  • Zuleica B. Fortes
    From the Institute of Biomedical Sciences (A.Z.C., E.Z.S., L.L.C., L.R.L., M.H.C.C., Z.B.F., R.C.T.), and Heart Institute, School of Medicine (A.Z.C., F.R.L.), University of São Paulo, São Paulo, Brazil; Kidney Research Centre (A.Z.C., E.Z.S., A.C.M., G.E.C., R.M.T.), Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada; Section of Experimental Endocrinology (M.C.W.A.), Department of Pharmacology, Federal University of São Paulo, Sao Paulo, Brazil; Department of...
  • Rhian M. Touyz
    From the Institute of Biomedical Sciences (A.Z.C., E.Z.S., L.L.C., L.R.L., M.H.C.C., Z.B.F., R.C.T.), and Heart Institute, School of Medicine (A.Z.C., F.R.L.), University of São Paulo, São Paulo, Brazil; Kidney Research Centre (A.Z.C., E.Z.S., A.C.M., G.E.C., R.M.T.), Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada; Section of Experimental Endocrinology (M.C.W.A.), Department of Pharmacology, Federal University of São Paulo, Sao Paulo, Brazil; Department of...
  • Rita C. Tostes
    From the Institute of Biomedical Sciences (A.Z.C., E.Z.S., L.L.C., L.R.L., M.H.C.C., Z.B.F., R.C.T.), and Heart Institute, School of Medicine (A.Z.C., F.R.L.), University of São Paulo, São Paulo, Brazil; Kidney Research Centre (A.Z.C., E.Z.S., A.C.M., G.E.C., R.M.T.), Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada; Section of Experimental Endocrinology (M.C.W.A.), Department of Pharmacology, Federal University of São Paulo, Sao Paulo, Brazil; Department of...

抄録

<jats:p> Testosterone has been implicated in vascular remodeling associated with hypertension. Molecular mechanisms underlying this are elusive, but oxidative stress may be important. We hypothesized that testosterone stimulates generation of reactive oxygen species (ROS) and migration of vascular smooth muscle cells (VSMCs), with enhanced effects in cells from spontaneously hypertensive rats (SHRs). The mechanisms (genomic and nongenomic) whereby testosterone induces ROS generation and the role of c-Src, a regulator of redox-sensitive migration, were determined. VSMCs from male Wistar-Kyoto rats and SHRs were stimulated with testosterone (10 <jats:sup>−7</jats:sup> mol/L, 0–120 minutes). Testosterone increased ROS generation, assessed by dihydroethidium fluorescence and lucigenin-enhanced chemiluminescence (30 minutes [SHR] and 60 minutes [both strains]). Flutamide (androgen receptor antagonist) and actinomycin D (gene transcription inhibitor) diminished ROS production (60 minutes). Testosterone increased <jats:italic>Nox1</jats:italic> and <jats:italic>Nox4</jats:italic> mRNA levels and p47phox protein expression, determined by real-time PCR and immunoblotting, respectively. Flutamide, actinomycin D, and cycloheximide (protein synthesis inhibitor) diminished testosterone effects on p47phox. c-Src phosphorylation was observed at 30 minutes (SHR) and 120 minutes (Wistar-Kyoto rat). Testosterone-induced ROS generation was repressed by 3-(4-chlorophenyl) 1-(1,1-dimethylethyl)-1H-pyrazolo[3,4-day]pyrimidin-4-amine (c-Src inhibitor) in SHRs and reduced by apocynin (antioxidant/NADPH oxidase inhibitor) in both strains. Testosterone stimulated VSMCs migration, assessed by the wound healing technique, with greater effects in SHRs. Flutamide, apocynin, and 3-(4-chlorophenyl) 1-(1,1-dimethylethyl)-1H-pyrazolo[3,4-day]pyrimidin-4-amine blocked testosterone-induced VSMCs migration in both strains. Our study demonstrates that testosterone induces VSMCs migration via NADPH oxidase–derived ROS and c-Src–dependent pathways by genomic and nongenomic mechanisms, which are differentially regulated in VSMCs from Wistar-Kyoto rats and SHRs. </jats:p>

収録刊行物

  • Hypertension

    Hypertension 59 (6), 1263-1271, 2012-06

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ